Daniel Cantillon, MD, explained why the positive performance of Abbott's Aveir dual-chamber leadless pacemaker could lead to considerable improvements in patient care. 

Change is on the horizon for cath labs all over the world as more and more interventional cardiologists are starting to use coronary CT angiography to plan and guide PCI procedures. Patients, physicians, catheterization labs and healthcare systems all stand to gain from this growing trend.

The research, published in Stroke and Vascular Neurology, suggests that just four hours of physical activity per week can reduce the significance of a brain bleed.

The Heart Rhythm Society released a new expert consensus statement on the management of remote device clinics for implantable EP devices.

Results from a pivotal clinical trial presented as a late-breaker at Heart Rhythm 2023 indicate that a new leadless pacemaker technology can deliver cardiac resynchronization therapy in patients who were not able to be treated with conventional CRT and epicardial leads.

The use of left bundle branch area pacing (LBBAP) is growing in electrophysiology implanted devices. Two late-breaking studies at Heart Rhythm 2023 highlight the success of LBBAP as an alternative to the standard of care using biventricular pacing.

Heart transplantation centers have significant risks to consider when donors test positive for COVID-19, according to new research published in the Journal of the American College of Cardiology.

Bruce Wilkoff, MD, director of cardiac pacing and tachyarrhythmia devices at Cleveland Clinic, said the new device could be "an important advancement for heart failure patients."